The Impact of N-acetylcysteine before RadioFrequency Catheter Ablation in Patients with Atrial Fibrillation on Recurrence of Atrial Fibrillation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000655

Enrollment

100

Registered

2013-02-04

Start date

2013-01-29

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The Impact of N-acetylcysteine before RadioFrequency Catheter Ablation in Patients with Atrial Fibrillation on Recurrence of Atrial Fibrillation * N-acetylcyteine dose : 50mg/kg IV 1hr before R

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? Drug refractory atrial fibrillation patients that radiofrequecy catheter ablation will be done ? patients who agree with this study ? older than 20 years old

Exclusion criteria

Exclusion criteria: ? patients with atrial fibrillation recurrence after radiofrequency catheter ablation ? patients with low left ventricular ejection fraction ? patients with valvular heart diseases ? patients with hypertrophic cardiomyopathy ? patients with stroke history

Design outcomes

Primary

Measure	Time frame
Impact of N-acetylcysteine before RadioFrequency Catheter Ablation in Patients with Atrial Fibrillation on Recurrence of Atrial Fibrillation	—

Secondary

Measure	Time frame
mpact of N-acetylcysteine before RadioFrequency Catheter Ablation in Patients with Atrial Fibrillation on clinical oucomes of Atrial Fibrillation	—

Countries

Korea, Republic of

Contacts

Public ContactSung Il Im

Koera University Guro Hospital

Outcome results